{"DataElement":{"publicId":"5644563","version":"1","preferredName":"Testicular Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Tumor T Stage","preferredDefinition":"Extent of the primary testicular carcinoma based on evidence obtained from pathologic examination through completion of definitive surgery.","longName":"5644535v1.0:5644371v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"5644535","version":"1","preferredName":"Malignant Testicular Germ Cell Tumor Pathologic T Stage","preferredDefinition":"A malignant tumor predominantly affecting young men and often associated with cryptorchidism.  Seminoma is the most frequently seen malignant testicular germ cell tumor, followed by embryonal carcinoma and yolk sac tumor._Caused by or altered by or manifesting disease or pathology._One criteria of the TNM staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"2986052v1.0:2207099v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2986052","version":"1","preferredName":"Malignant Testicular Germ Cell Tumor","preferredDefinition":"A malignant tumor predominantly affecting young men and often associated with cryptorchidism.  Seminoma is the most frequently seen malignant testicular germ cell tumor, followed by embryonal carcinoma and yolk sac tumor. -- 2004","longName":"C9063","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Testicular Germ Cell Tumor","conceptCode":"C9063","definition":"A malignant germ cell tumor that arises from the testis. It predominantly affects young men. Seminoma is the most frequently seen malignant testicular germ cell tumor, followed by embryonal carcinoma and yolk sac tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7D112249-82D8-E0FD-E040-BB89AD432FCB","latestVersionIndicator":"Yes","beginDate":"2010-01-13","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-01-13","modifiedBy":"ONEDATA","dateModified":"2010-01-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207099","version":"1","preferredName":"Pathologic T Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25610:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-1838-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"47666226-FFAC-097E-E053-F662850AD9C2","latestVersionIndicator":"Yes","beginDate":"2017-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-31","modifiedBy":"COOPERM","dateModified":"2017-01-31","changeDescription":"Created for CRF standard harmonization. mc 1/31/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5644371","version":"1","preferredName":"Testicular Cancer American Joint Committee on Cancer Edition 7 T Stage","preferredDefinition":"A finding about one or more characteristics of testicular cancer, following the rules of the TNM AJCC v7 classification system._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"5644371v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"pT0","valueDescription":"Testicular Cancer pT0 TNM Finding v7","ValueMeaning":{"publicId":"5644373","version":"1","preferredName":"Testicular Cancer pT0 TNM Finding v7","longName":"5644373","preferredDefinition":"No evidence of primary tumor (e.g., histologic scar in testis). (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testicular Cancer pT0 TNM Finding v7","conceptCode":"C89240","definition":"No evidence of primary tumor (e.g., histologic scar in testis). (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4765131A-97E5-134B-E053-F662850A3841","latestVersionIndicator":"Yes","beginDate":"2017-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4765131A-97FE-134B-E053-F662850A3841","beginDate":"2017-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-31","modifiedBy":"ONEDATA","dateModified":"2017-01-31","deletedIndicator":"No"},{"value":"pT1","valueDescription":"Testicular Cancer pT1 TNM Finding v7","ValueMeaning":{"publicId":"5644375","version":"1","preferredName":"Testicular Cancer pT1 TNM Finding v7","longName":"5644375","preferredDefinition":"Testicular cancer with tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade into the tunica albuginea but not the tunica vaginalis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testicular Cancer pT1 TNM Finding v7","conceptCode":"C89242","definition":"Testicular cancer with tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade into the tunica albuginea but not the tunica vaginalis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4765131A-980B-134B-E053-F662850A3841","latestVersionIndicator":"Yes","beginDate":"2017-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4765131A-9824-134B-E053-F662850A3841","beginDate":"2017-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-31","modifiedBy":"ONEDATA","dateModified":"2017-01-31","deletedIndicator":"No"},{"value":"pT2","valueDescription":"Testicular Cancer pT2 TNM Finding v7","ValueMeaning":{"publicId":"5644377","version":"1","preferredName":"Testicular Cancer pT2 TNM Finding v7","longName":"5644377","preferredDefinition":"Testicular cancer with tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testicular Cancer pT2 TNM Finding v7","conceptCode":"C89243","definition":"Testicular cancer with tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4765131A-9831-134B-E053-F662850A3841","latestVersionIndicator":"Yes","beginDate":"2017-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4765131A-984A-134B-E053-F662850A3841","beginDate":"2017-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-31","modifiedBy":"ONEDATA","dateModified":"2017-01-31","deletedIndicator":"No"},{"value":"pT3","valueDescription":"Testicular Cancer pT3 TNM Finding v7","ValueMeaning":{"publicId":"5644379","version":"1","preferredName":"Testicular Cancer pT3 TNM Finding v7","longName":"5644379","preferredDefinition":"Testicular cancer with tumor invading the spermatic cord with or without vascular/lymphatic invasion. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testicular Cancer pT3 TNM Finding v7","conceptCode":"C89244","definition":"Testicular cancer with tumor invading the spermatic cord with or without vascular/lymphatic invasion. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4765131A-9857-134B-E053-F662850A3841","latestVersionIndicator":"Yes","beginDate":"2017-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4765131A-9870-134B-E053-F662850A3841","beginDate":"2017-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-31","modifiedBy":"ONEDATA","dateModified":"2017-01-31","deletedIndicator":"No"},{"value":"pT4","valueDescription":"Testicular Cancer pT4 TNM Finding v7","ValueMeaning":{"publicId":"5644381","version":"1","preferredName":"Testicular Cancer pT4 TNM Finding v7","longName":"5644381","preferredDefinition":"Testicular cancer with tumor invading the scrotum with or without vascular/lymphatic invasion. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testicular Cancer pT4 TNM Finding v7","conceptCode":"C89245","definition":"Testicular cancer with tumor invading the scrotum with or without vascular/lymphatic invasion. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4765131A-987D-134B-E053-F662850A3841","latestVersionIndicator":"Yes","beginDate":"2017-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4765131A-9896-134B-E053-F662850A3841","beginDate":"2017-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-31","modifiedBy":"ONEDATA","dateModified":"2017-01-31","deletedIndicator":"No"},{"value":"pTis","valueDescription":"Testicular Cancer pTis TNM Finding v7","ValueMeaning":{"publicId":"5644383","version":"1","preferredName":"Testicular Cancer pTis TNM Finding v7","longName":"5644383","preferredDefinition":"Intratubular germ cell neoplasia (carcinoma in situ). (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testicular Cancer pTis TNM Finding v7","conceptCode":"C89241","definition":"Intratubular germ cell neoplasia (carcinoma in situ). (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4765131A-98A3-134B-E053-F662850A3841","latestVersionIndicator":"Yes","beginDate":"2017-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4765131A-98BC-134B-E053-F662850A3841","beginDate":"2017-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-31","modifiedBy":"ONEDATA","dateModified":"2017-01-31","deletedIndicator":"No"},{"value":"pTX","valueDescription":"Testicular Cancer pTX TNM Finding v7","ValueMeaning":{"publicId":"5644385","version":"1","preferredName":"Testicular Cancer pTX TNM Finding v7","longName":"5644385","preferredDefinition":"Testicular cancer in which the primary tumor cannot be assessed. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testicular Cancer pTX TNM Finding v7","conceptCode":"C89239","definition":"Testicular cancer in which the primary tumor cannot be assessed. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4765131A-98C9-134B-E053-F662850A3841","latestVersionIndicator":"Yes","beginDate":"2017-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4765131A-98E2-134B-E053-F662850A3841","beginDate":"2017-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-31","modifiedBy":"ONEDATA","dateModified":"2017-01-31","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5644370","version":"1","preferredName":"Testicular Cancer TNM Finding v7 American Joint Committee on Cancer T Stage Stage","preferredDefinition":"A finding about one or more characteristics of testicular cancer, following the rules of the TNM AJCC v7 classification system.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C89236:C39315:C25728:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testicular Cancer TNM Finding v7","conceptCode":"C89236","definition":"A finding about one or more characteristics of testicular cancer, following the rules of the TNM AJCC v7 classification system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4765131A-97B7-134B-E053-F662850A3841","latestVersionIndicator":"Yes","beginDate":"2017-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-31","modifiedBy":"ONEDATA","dateModified":"2017-01-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4765131A-97C8-134B-E053-F662850A3841","latestVersionIndicator":"Yes","beginDate":"2017-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-31","modifiedBy":"COOPERM","dateModified":"2017-01-31","changeDescription":"Created for CRF standard harmonization. mc 1/30/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"5777529","version":"1","longName":"Testicular","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pathologic T Stage","type":"Preferred Question Text","description":"Pathologic T Stage","url":null,"context":"NCI Standards"},{"name":"AJCC Ed.7 Information Related to T Stage","type":"COMMENT","description":"The extent of primary tumor is usually classified after radical orchiectomy and, for this reason, a pathologic stage is assigned.","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"47664DF1-1DB2-333F-E053-F662850A9C02","latestVersionIndicator":"Yes","beginDate":"2017-01-31","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-01-31","modifiedBy":"TAYLORT","dateModified":"2017-04-19","changeDescription":"Created for CRF Harmonization. mc 1/31/17","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}